HB 1333 — Individualized Investigational Treatments
Last action — Died in Health Professions & Programs Subcommittee
-
✓Introduced
-
2In Committee
-
3Passed House
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill died with 2025 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.
Summary
Individualized Investigational Treatments ; Authorizes certain actions by eligible facilities, manufacturers operating within eligible facilities, & eligible patients relating to individualized investigational treatments; authorizes health plans, third-party administrators, & governmental agencies to provide coverage for cost of individualized investigational drug, biological product, or device, or cost of certain services; limits liability; prohibits licensing boards, disciplinary subcommittees, & entities responsible for Medicare certification from taking certain actions against health care provider's license; prohibits certain persons from blocking or attempting to block eligible patient's access to individualized investigational drug, biological product, or device; provides construction.
Bill Text
- Introduced H 1333 Filed Current pdf
Action History
-
Died in Health Professions & Programs Subcommittee
-
Indefinitely postponed and withdrawn from consideration
-
Now in Health Professions & Programs Subcommittee
-
Referred to Health & Human Services Committee
-
Referred to Budget Committee
-
Referred to Health Professions & Programs Subcommittee
-
1st Reading (Original Filed Version)
-
Filed
Sponsors
- Anne Gerwig · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 163 not signed on
Sponsors (1)
- Gerwig, Anne Republican
Co-sponsors (0)
None.
Not signed on (163)
163 members have not signed on to this bill.
Show all 163 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does HB 1333 do?
- Individualized Investigational Treatments ; Authorizes certain actions by eligible facilities, manufacturers operating within eligible facilities, & eligible patients relating to individualized investigational treatments; authorizes health plans, third-party administrators, & governmental agencies to provide coverage for cost of individualized investigational drug, biological product, or device, or cost of certain services; limits liability; prohibits licensing boards, disciplinary subcommittees, & entities responsible for Medicare certification from taking certain actions against health care provider's license; prohibits certain persons from blocking or attempting to block eligible patient's access to individualized investigational drug, biological product, or device; provides construction.
- Who sponsors HB 1333?
- HB 1333 is sponsored by Gerwig, Anne (Republican).
- What is the current status of HB 1333?
- This bill died with 2025 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track HB 1333?
- Track HB 1333 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HB 1333
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HB 1333
Last checked for changes 2 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →